arginyllysine: Clinical Trials

1 trial of arginyllysine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow arginyllysine: new trials by email Literature Review of arginyllysine trials Research Report on arginyllysine

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs
Satoreotide tetraxetan, Amino acid solution, Antiemetic - Neuroendocrine Tumors
Phase 1 / Phase 2TerminatedIpsen402017-03-062023-07-19

Conditions studied

Neuroendocrine Tumors (1)

Sponsors

Ipsen (1)

Countries

Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 37721581, PMID 38528164

NIH funding

2015 (1)